We are live on
!
Find out more
MRCM
M&R Capital Management Portfolio holdings
AUM
$454M
1-Year Est. Return
40.11%
This Fund
S&P 500
This Quarter
Est. Return
+1.51%
1 Year Est. Return
+40.11%
3 Year Est. Return
+52.56%
5 Year Est. Return
+141.03%
10 Year Est. Return
+275.44%
AUM
$414M
AUM Growth
+$32.3M
(+8.5%)
Cap. Flow
+$27.9M
Cap. Flow
% of AUM
6.73%
Top 10 Holdings %
Top 10 Hldgs %
30.48%
Holding
216
New
11
Increased
89
Reduced
59
Closed
8
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$8.36M |
| 2 |
NOV
NOV
|
+$1.18M |
| 3 |
GNC
GNC Holdings, Inc.
GNC
|
+$936K |
| 4 |
Visa
V
|
+$812K |
| 5 |
ESRX
Express Scripts Holding Company
ESRX
|
+$805K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Philip Morris
PM
|
+$501K |
| 2 |
Teva Pharmaceuticals
TEVA
|
+$380K |
| 3 |
PCL
PLUM CREEK TIMBER CO (REIT)
PCL
|
+$326K |
| 4 |
Liberty Global Class A
LBTYA
|
+$282K |
| 5 |
Biogen
BIIB
|
+$280K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.03% |
| 2 | Miscellaneous | 15.33% |
| 3 | Financials | 12.38% |
| 4 | Industrials | 11.36% |
| 5 | Technology | 10.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
BlackRock Credit Allocation Income Trust
BTZ
$946M
| $4.36M | 1.05% |
322,677
-5,100
| -2% | -$67.5K |
|
27
Church & Dwight Co
CHD
$24B
| $4.33M | 1.04% |
125,380
| – | – |
|
|
CSI
28
DELISTED
Cutwater Select Income Fund
CSI
| $3.88M | 0.94% |
199,621
-3,550
| -2% | -$66.2K |
|
29
State Street
STT
$53.1B
| $3.86M | 0.93% |
55,464
-300
| -0.5% | -$20.7K |
|
30
Pfizer
PFE
$159B
| $3.8M | 0.92% |
124,628
-1,866
| -1% | -$55.6K |
|
31
Devon Energy
DVN
$52.1B
| $3.56M | 0.86% |
53,229
+2,149
| +4% | +$133K |
|
32
Colgate-Palmolive
CL
$72.3B
| $3.42M | 0.83% |
52,751
-250
| -0.5% | -$15.8K |
|
33
Procter & Gamble
PG
$334B
| $3.29M | 0.79% |
40,804
+1,110
| +3% | +$87.5K |
|
34
GE Aerospace
GE
$355B
| $3M | 0.72% |
24,156
+379
| +2% | +$46.8K |
|
|
AFM.CL
35
DELISTED
Affiliated Managers Group Inc Sr NT 5.250% Due 2022
AFM.CL
| $2.81M | 0.68% |
109,611
-800
| -0.7% | -$20.4K |
|
36
Apple
AAPL
$4.67T
| $2.78M | 0.67% |
145,180
+8,764
| +6% | +$167K |
|
37
SLB Ltd
SLB
$85.1B
| $2.78M | 0.67% |
28,476
+295
| +1% | +$26.7K |
|
38
Henry Schein
HSIC
$9.98B
| $2.75M | 0.66% |
58,650
-2,104
| -3% | -$96.2K |
|
39
Wells Fargo
WFC
$262B
| $2.55M | 0.62% |
51,304
+2,507
| +5% | +$117K |
|
40
Chevron
CVX
$396B
| $2.47M | 0.6% |
20,741
+328
| +2% | +$38.1K |
|
41
Microsoft
MSFT
$3.81T
| $2.45M | 0.59% |
59,684
-673
| -1% | -$25.3K |
|
42
Plains All American Pipeline
PAA
$18B
| $2.1M | 0.51% |
38,190
+8,250
| +28% | +$433K |
|
43
CVS Health
CVS
$119B
| $2.07M | 0.5% |
27,636
-75
| -0.3% | -$5.3K |
|
44
Waste Management
WM
$87.8B
| $2.05M | 0.49% |
48,680
-2,221
| -4% | -$93.1K |
|
45
Merck
MRK
$366B
| $2.02M | 0.49% |
37,353
+1,075
| +3% | +$55.7K |
|
46
Verizon
VZ
$208B
| $1.86M | 0.45% |
39,059
+8,323
| +27% | +$394K |
|
47
Coca-Cola
KO
$386B
| $1.72M | 0.42% |
44,510
-250
| -0.6% | -$9.66K |
|
48
NextEra Energy
NEE
$171B
| $1.7M | 0.41% |
71,068
-640
| -0.9% | -$14.5K |
|
49
Kinder Morgan
KMI
$70.3B
| $1.61M | 0.39% |
49,590
+600
| +1% | +$20.1K |
|
50
Bristol-Myers Squibb
BMY
$136B
| $1.59M | 0.38% |
30,565
+4
| +0% | +$213 |
|
Similar funds
EDRIA
SFP
AC
NIC
WCA
KC
SIGI
FPFS
M&R Capital Management's Q1 2014 Portfolio in Review
As of Q1 2014, M&R Capital Management held 216 positions worth $414M, up 8.5% from $382M the previous quarter. Its ten largest holdings account for 30% of the portfolio.
M&R Capital Management deployed $27.9M of net new capital in Q1 2014, opening 11 new positions and adding to 89 existing holdings. Its largest new stake was Magellan Midstream Partners, L.P.: 5,800 shares worth $404K.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 15% a quarter earlier, followed by Miscellaneous and Financials.
On the sell side, the largest reduction was Philip Morris, an estimated $501K trimmed.
- M&R Capital Management's largest Q1 2014 buy was Magellan Midstream Partners, L.P.: 5,800 shares worth $404K.
- M&R Capital Management added most to Allergan plc in Q1 2014, an estimated $8.36M increase.
- M&R Capital Management's biggest Q1 2014 reduction was Philip Morris, cutting an estimated $501K.
- M&R Capital Management fully exited Teva Pharmaceuticals in Q1 2014, selling an estimated $380K.
- M&R Capital Management's ten largest holdings make up 30% of its $414M portfolio in Q1 2014.
- M&R Capital Management opened 11 new positions and closed 8 in Q1 2014.
- M&R Capital Management's portfolio value rose 8.5% quarter-over-quarter to $414M.
Based on M&R Capital Management's 13F filing for Q1 2014, filed 2 May 2014.